Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma

Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of hematology 2022-07, Vol.101 (7), p.1609-1610
Hauptverfasser: Takakuwa, Teruhito, Okayama, Yusuke, Nakamae, Hirohisa, Kuno, Masatomo, Makuuchi, Yosuke, Harada, Naonori, Okamura, Hiroshi, Nishimoto, Mitsutaka, Nakashima, Yasuhiro, Koh, Hideo, Hino, Masayuki
Format: Artikel
Sprache:eng
Schlagworte:
Hematology
Letter to the Editor
Medicine
Medicine & Public Health
Oncology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1610
container_issue 7
container_start_page 1609
container_title Annals of hematology
container_volume 101
creator Takakuwa, Teruhito
Okayama, Yusuke
Nakamae, Hirohisa
Kuno, Masatomo
Makuuchi, Yosuke
Harada, Naonori
Okamura, Hiroshi
Nishimoto, Mitsutaka
Nakashima, Yasuhiro
Koh, Hideo
Hino, Masayuki
description
doi_str_mv 10.1007/s00277-022-04803-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2633902680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2677213591</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-96e4b4b132cfdc320c6e26a028098009bbd08e9fb705a64cb1ce816cb045ae1b3</originalsourceid><addsrcrecordid>eNp9kc9uFSEUh4nR2OvVF3BhSNy4GT3A_IGlNlZNmuhC1wSYMy3NMFxhqN4-gw9dbm_VxIVsCJyPj5PzI-Q5g9cMYHiTAfgwNMB5A60E0cADsmGtqMdOtg_JBpRQTVfXCXmS8xUA47Llj8mJ6DiTQskN-fUlzmYtNyUYS69xjKtfqIvB-gVH-sOvlzT5tfz0td5YXEYTSq4MUh8Cjt6sOO-pxSkmpHnFQB3OMw3R-tnfmNXHhVZjwtnscjWOfppKRjqbdIH0XXNHz_uwu4zBPCWPJjNnfHa_b8m3s_dfTz82558_fDp9e944wfu1UT22trVMcDeN9Qpcj7w3wCUoCaCsHUGimuwAnelbZ5lDyXpnoe0MMiu25NXRu0vxe8G86uDzoROzYCxZ814IBbyvM92Sl_-gV7GkpXZXqWHgTHSKVYofKZdizgknvUt1YmmvGehDVvqYla5Z6bus9EH94l5dbB3lnye_w6mAOAK5lpYLTH___o_2FsnvogM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2677213591</pqid></control><display><type>article</type><title>Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma</title><source>Springer Nature - Complete Springer Journals</source><creator>Takakuwa, Teruhito ; Okayama, Yusuke ; Nakamae, Hirohisa ; Kuno, Masatomo ; Makuuchi, Yosuke ; Harada, Naonori ; Okamura, Hiroshi ; Nishimoto, Mitsutaka ; Nakashima, Yasuhiro ; Koh, Hideo ; Hino, Masayuki</creator><creatorcontrib>Takakuwa, Teruhito ; Okayama, Yusuke ; Nakamae, Hirohisa ; Kuno, Masatomo ; Makuuchi, Yosuke ; Harada, Naonori ; Okamura, Hiroshi ; Nishimoto, Mitsutaka ; Nakashima, Yasuhiro ; Koh, Hideo ; Hino, Masayuki</creatorcontrib><identifier>ISSN: 0939-5555</identifier><identifier>EISSN: 1432-0584</identifier><identifier>DOI: 10.1007/s00277-022-04803-0</identifier><identifier>PMID: 35218398</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Hematology ; Letter to the Editor ; Medicine ; Medicine &amp; Public Health ; Oncology</subject><ispartof>Annals of hematology, 2022-07, Vol.101 (7), p.1609-1610</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-96e4b4b132cfdc320c6e26a028098009bbd08e9fb705a64cb1ce816cb045ae1b3</cites><orcidid>0000-0001-5259-0450</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00277-022-04803-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00277-022-04803-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35218398$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takakuwa, Teruhito</creatorcontrib><creatorcontrib>Okayama, Yusuke</creatorcontrib><creatorcontrib>Nakamae, Hirohisa</creatorcontrib><creatorcontrib>Kuno, Masatomo</creatorcontrib><creatorcontrib>Makuuchi, Yosuke</creatorcontrib><creatorcontrib>Harada, Naonori</creatorcontrib><creatorcontrib>Okamura, Hiroshi</creatorcontrib><creatorcontrib>Nishimoto, Mitsutaka</creatorcontrib><creatorcontrib>Nakashima, Yasuhiro</creatorcontrib><creatorcontrib>Koh, Hideo</creatorcontrib><creatorcontrib>Hino, Masayuki</creatorcontrib><title>Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma</title><title>Annals of hematology</title><addtitle>Ann Hematol</addtitle><addtitle>Ann Hematol</addtitle><subject>Hematology</subject><subject>Letter to the Editor</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><issn>0939-5555</issn><issn>1432-0584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kc9uFSEUh4nR2OvVF3BhSNy4GT3A_IGlNlZNmuhC1wSYMy3NMFxhqN4-gw9dbm_VxIVsCJyPj5PzI-Q5g9cMYHiTAfgwNMB5A60E0cADsmGtqMdOtg_JBpRQTVfXCXmS8xUA47Llj8mJ6DiTQskN-fUlzmYtNyUYS69xjKtfqIvB-gVH-sOvlzT5tfz0td5YXEYTSq4MUh8Cjt6sOO-pxSkmpHnFQB3OMw3R-tnfmNXHhVZjwtnscjWOfppKRjqbdIH0XXNHz_uwu4zBPCWPJjNnfHa_b8m3s_dfTz82558_fDp9e944wfu1UT22trVMcDeN9Qpcj7w3wCUoCaCsHUGimuwAnelbZ5lDyXpnoe0MMiu25NXRu0vxe8G86uDzoROzYCxZ814IBbyvM92Sl_-gV7GkpXZXqWHgTHSKVYofKZdizgknvUt1YmmvGehDVvqYla5Z6bus9EH94l5dbB3lnye_w6mAOAK5lpYLTH___o_2FsnvogM</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>Takakuwa, Teruhito</creator><creator>Okayama, Yusuke</creator><creator>Nakamae, Hirohisa</creator><creator>Kuno, Masatomo</creator><creator>Makuuchi, Yosuke</creator><creator>Harada, Naonori</creator><creator>Okamura, Hiroshi</creator><creator>Nishimoto, Mitsutaka</creator><creator>Nakashima, Yasuhiro</creator><creator>Koh, Hideo</creator><creator>Hino, Masayuki</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5259-0450</orcidid></search><sort><creationdate>20220701</creationdate><title>Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma</title><author>Takakuwa, Teruhito ; Okayama, Yusuke ; Nakamae, Hirohisa ; Kuno, Masatomo ; Makuuchi, Yosuke ; Harada, Naonori ; Okamura, Hiroshi ; Nishimoto, Mitsutaka ; Nakashima, Yasuhiro ; Koh, Hideo ; Hino, Masayuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-96e4b4b132cfdc320c6e26a028098009bbd08e9fb705a64cb1ce816cb045ae1b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Hematology</topic><topic>Letter to the Editor</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takakuwa, Teruhito</creatorcontrib><creatorcontrib>Okayama, Yusuke</creatorcontrib><creatorcontrib>Nakamae, Hirohisa</creatorcontrib><creatorcontrib>Kuno, Masatomo</creatorcontrib><creatorcontrib>Makuuchi, Yosuke</creatorcontrib><creatorcontrib>Harada, Naonori</creatorcontrib><creatorcontrib>Okamura, Hiroshi</creatorcontrib><creatorcontrib>Nishimoto, Mitsutaka</creatorcontrib><creatorcontrib>Nakashima, Yasuhiro</creatorcontrib><creatorcontrib>Koh, Hideo</creatorcontrib><creatorcontrib>Hino, Masayuki</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takakuwa, Teruhito</au><au>Okayama, Yusuke</au><au>Nakamae, Hirohisa</au><au>Kuno, Masatomo</au><au>Makuuchi, Yosuke</au><au>Harada, Naonori</au><au>Okamura, Hiroshi</au><au>Nishimoto, Mitsutaka</au><au>Nakashima, Yasuhiro</au><au>Koh, Hideo</au><au>Hino, Masayuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma</atitle><jtitle>Annals of hematology</jtitle><stitle>Ann Hematol</stitle><addtitle>Ann Hematol</addtitle><date>2022-07-01</date><risdate>2022</risdate><volume>101</volume><issue>7</issue><spage>1609</spage><epage>1610</epage><pages>1609-1610</pages><issn>0939-5555</issn><eissn>1432-0584</eissn><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>35218398</pmid><doi>10.1007/s00277-022-04803-0</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-5259-0450</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0939-5555
ispartof Annals of hematology, 2022-07, Vol.101 (7), p.1609-1610
issn 0939-5555
1432-0584
language eng
recordid cdi_proquest_miscellaneous_2633902680
source Springer Nature - Complete Springer Journals
subjects Hematology
Letter to the Editor
Medicine
Medicine & Public Health
Oncology
title Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T11%3A01%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polatuzumab%20vedotin%20combined%20with%20rituximab-bendamustine%20immediately%20before%20stem%20cell%20mobilization%20in%20relapsed%20diffuse%20large%20B-cell%20lymphoma&rft.jtitle=Annals%20of%20hematology&rft.au=Takakuwa,%20Teruhito&rft.date=2022-07-01&rft.volume=101&rft.issue=7&rft.spage=1609&rft.epage=1610&rft.pages=1609-1610&rft.issn=0939-5555&rft.eissn=1432-0584&rft_id=info:doi/10.1007/s00277-022-04803-0&rft_dat=%3Cproquest_cross%3E2677213591%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2677213591&rft_id=info:pmid/35218398&rfr_iscdi=true